Exosomes and their distinct integrins transfer the characteristics of oxaliplatin- and 5-FU-resistant behaviors in colorectal cancer cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Exosome integrins influence chemoresistance in colorectal cancer. Targeting exosomal integrins like ITGβ3, ITGαv, and ITGβ4 may offer new diagnostic and therapeutic strategies for oxaliplatin and 5-FU resistance.
Area Of Science
- Molecular Biology
- Cancer Research
- Cell Biology
Background
- Exosomes act as intercellular communication mediators, carrying cargo with dynamic profiles relevant for biomarker discovery.
- Integrins are crucial prognostic markers in cancer, playing a role in exosome-cell interactions.
- The specific function of exosome integrins in chemoresistant colorectal cancer remains largely unexplored.
Purpose Of The Study
- To investigate the role and impact of exosomal integrins in the development of chemoresistance in colorectal cancer.
- To determine if specific exosome integrins can predict or influence resistance to oxaliplatin and 5-FU treatments.
- To explore the potential of exosomal integrins as diagnostic and therapeutic targets in colorectal cancer.
Main Methods
- Established oxaliplatin- and 5-FU-resistant colorectal cancer cell lines (OXR and FUR) from HCT-116 cells.
- Isolated and characterized exosomes from untreated and chemotherapy-treated cells using ultracentrifugation, DLS, and electron microscopy.
- Assessed the effects of exosomes on parental cells, evaluating proliferation, migration, cell cycle, apoptosis, invasion, and integrin expression via MTT, wound healing, flow cytometry, transwell assays, and Western blot.
Main Results
- Exosomes from OXR cells modulated integrin expression (increased ITGβ3, decreased ITGβ4) in parental cells, inducing oxaliplatin resistance.
- Exosomes from FUR cells altered integrin levels (decreased ITGβ4, elevated ITGαv) in parental cells, promoting invasive chemoresistance to 5-FU.
- Manipulating exosomal ITGβ3, ITGαv, and ITGβ4 levels directly impacted chemoresistance behaviors, including proliferation, migration, and invasion.
Conclusions
- Exosomal integrins (ITGβ3, ITGαv, ITGβ4) significantly influence chemoresistance phenotypes in colorectal cancer cells.
- Despite cellular integrin pattern discrepancies, exosomal integrin levels correlate with resistance behaviors.
- Exosomal integrins represent promising diagnostic and therapeutic biomarkers for overcoming oxaliplatin and 5-FU resistance in colorectal cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...